Found 7 matching trials
A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients PHASE3 A Phase III, Multicenter, open-labeded study to Evaluate Efficacy and Safet...
Show More Location
Beijing Tsinghua Changgung Hospital
Learn More & Join Trial
To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects PHASE1 To evaluate the pharmacokinetics and safety of Yimitasvir phosphate capsule...
Show More Location
West China Hospital of Sichuan University
Learn More & Join Trial
Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD PHASE1 This study is to evaluate the single-dose pharmacokinetics (PK) and safety ...
Show More Location
West China Hospital of Sichuan University
Learn More & Join Trial
Phase 3 Study of Yimitasvir Phosphate Capsules PHASE3 The safety, tolerability and antiviral activity of DAG181/SOF in treatment-...
Show More Location
Beijing Ditan Hospital Affiliated to Capital Medical University
Learn More & Join Trial
Phase 2 Study of Yimitasvir Phosphate Capsules PHASE2 The safety, tolerability and antiviral activity of DAG181/SOF in treatment-...
Show More Location
Peking University First Hospital
Learn More & Join Trial
The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects PHASE1 The Safety, Tolerability and Pharmacokinetic Study of Chronic Hepatitis C T...
Show More Location
Peking University First Hospital
Learn More & Join Trial
To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers PHASE1 To evaluate the drug-drug reactions between TG-2349 and DAG181, and the pha...
Show More Location
Xiangya Hospital Central South University
Learn More & Join Trial